New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 30, 2014
08:39 EDTSQNMSequenom should be bought following solid Q2, says Maxim
Maxim raised its price target for Sequenom shares to $7 from $6 and recommends buying the stock following the company's "solid" Q2 results. Maxim expects Sequenom to regain its leadership position after the firm's channel checks in Q2 indicated Ariosa's U.S. volume may have surpassed Sequenom for the first time in Q2. It keeps a Buy rating on the stock.
News For SQNM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 23, 2015
15:46 EDTSQNMPiper Jaffray's medtech analysts hold an analyst/industry conference call
Subscribe for More Information
January 22, 2015
07:04 EDTSQNMSequenom and Cypher Genomics sign prenatal test development agreement
Subscribe for More Information
January 20, 2015
13:45 EDTSQNMIllumina rises as genomics project seen being announced in State of the Union
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use